EG23992A - Container with freeze-dried vaccine components - Google Patents

Container with freeze-dried vaccine components

Info

Publication number
EG23992A
EG23992A EG15097A EG15097A EG23992A EG 23992 A EG23992 A EG 23992A EG 15097 A EG15097 A EG 15097A EG 15097 A EG15097 A EG 15097A EG 23992 A EG23992 A EG 23992A
Authority
EG
Egypt
Prior art keywords
container
freeze
vaccine
vaccine components
dried vaccine
Prior art date
Application number
EG15097A
Other languages
English (en)
Inventor
Antonius T Wilderbeek
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of EG23992A publication Critical patent/EG23992A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Drying Of Solid Materials (AREA)
EG15097A 1996-03-07 1997-03-01 Container with freeze-dried vaccine components EG23992A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96200621 1996-03-07

Publications (1)

Publication Number Publication Date
EG23992A true EG23992A (en) 2008-03-09

Family

ID=8223754

Family Applications (1)

Application Number Title Priority Date Filing Date
EG15097A EG23992A (en) 1996-03-07 1997-03-01 Container with freeze-dried vaccine components

Country Status (19)

Country Link
US (2) US5897852A (xx)
EP (1) EP0799613B1 (xx)
JP (1) JP4293643B2 (xx)
KR (1) KR100458370B1 (xx)
CN (1) CN1133423C (xx)
AT (1) ATE202925T1 (xx)
AU (1) AU704629B2 (xx)
CA (1) CA2198195C (xx)
DE (1) DE69705569T2 (xx)
DK (1) DK0799613T3 (xx)
EG (1) EG23992A (xx)
ES (1) ES2161412T3 (xx)
GR (1) GR3036725T3 (xx)
HU (1) HU220532B1 (xx)
IL (1) IL120202A (xx)
NZ (1) NZ314267A (xx)
PT (1) PT799613E (xx)
SA (1) SA97170715B1 (xx)
ZA (1) ZA971734B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
AU779403B2 (en) * 1999-08-24 2005-01-20 Teva Pharmaceutical Industries Ltd. A vaccine composition and method of using the same
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US7863012B2 (en) * 2004-02-17 2011-01-04 Veridex, Llc Analysis of circulating tumor cells, fragments, and debris
AUPR750501A0 (en) * 2001-09-05 2001-09-27 Gauci, Mark Products comprising quantum of bioparticles and method for production thereof
US6780581B2 (en) 2001-09-12 2004-08-24 Btf Pty Ltd Products comprising quantum of bioparticles and method for production thereof
WO2013034682A1 (en) 2011-09-08 2013-03-14 Umc Utrecht Holding B.V. Vaccine based on staphylococcal superantigen- line 3 protein (ssl3)
MXPA06006896A (es) * 2003-12-19 2006-09-04 Alk Abello As Metodo de criogranulacion y almacenamiento para agentes farmaceuticos activos.
US20050181353A1 (en) * 2004-02-17 2005-08-18 Rao Galla C. Stabilization of cells and biological specimens for analysis
TWI436789B (zh) * 2008-01-21 2014-05-11 Intervet Int Bv 含有藥學化合物的顆粒之冷凍乾燥方法及含有此顆粒的藥學包
TWI444384B (zh) * 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
CA2716399C (en) 2008-03-05 2020-07-21 Pierre Chouvenc Process for stabilizing an adjuvant containing vaccine composition
EP2143440A1 (fr) * 2008-07-09 2010-01-13 Sanofi Pasteur Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués
TW201043267A (en) * 2009-03-19 2010-12-16 Intervet Int Bv In situ constituting a vaccine for administration to a predetermined herd of animals
EP2658568A1 (en) 2010-12-29 2013-11-06 Intervet International B.V. Canine babesiosis vaccine antigen
EP2773778B1 (en) 2011-10-31 2020-11-18 Merck Sharp & Dohme Corp. Methods of preparing lyophilized spherical-shaped pellets of biological materials
WO2017066134A1 (en) * 2015-10-16 2017-04-20 Merck Sharp & Dohme Corp. Processes for preparing formulations for gastrointestinal-targeted therapies
NL2018155B1 (en) 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease
CN113862332A (zh) * 2021-09-17 2021-12-31 浙江大学 琼脂糖在制备生物大分子冻干保护剂中的应用
CN114159555A (zh) * 2021-12-08 2022-03-11 江西赛基生物技术有限公司 抗原蛋白冻干小球及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655838A (en) * 1969-03-20 1972-04-11 Organon Method of pelletizing analytical or immunological reagents
US3932943A (en) * 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
NL174429C (nl) * 1971-09-03 1984-06-18 Du Pont Werkwijze voor het bereiden van gevriesdroogd serum of plasma.
US3857423A (en) * 1971-12-27 1974-12-31 W Ronca Topical medicament kit with interlocking components
US3893280A (en) * 1972-06-21 1975-07-08 Burns Biotec Lab Inc Transfer packaging for biologicals
US4351158A (en) * 1980-01-22 1982-09-28 American Home Products Corporation Method of producing multicomponent lyophilized product
US4295280A (en) * 1980-03-17 1981-10-20 American Home Products Corporation Method of obtaining a lyophilized product
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US4712310A (en) * 1986-09-15 1987-12-15 E. I. Du Pont De Nemours And Company Co-spray technique
IE61575B1 (en) 1987-05-04 1994-11-16 Merck & Co Inc A stable lyophilized live herpes virus vaccine
AT390192B (de) * 1988-08-29 1990-03-26 Immuno Ag Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen
US5044091B1 (en) * 1989-04-18 1997-12-30 Sankyo Co Method of preparing a freeze-dried formulation of a drug
WO1990013285A1 (en) * 1989-05-01 1990-11-15 Enzytech, Inc. Process for producing small particles of biologically active molecules
IE64738B1 (en) 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
CA2051092C (en) * 1990-09-12 2002-07-23 Stephen A. Livesey Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions
ATE146360T1 (de) * 1993-04-28 1997-01-15 Akzo Nobel Nv Gonadotropin enthaltende gefriergetrocknete troepfen
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components

Also Published As

Publication number Publication date
ES2161412T3 (es) 2001-12-01
ATE202925T1 (de) 2001-07-15
KR970064584A (ko) 1997-10-13
NZ314267A (en) 1998-01-26
HUP9700556A3 (en) 2000-04-28
DK0799613T3 (da) 2001-10-22
MX9701726A (es) 1998-03-31
CA2198195C (en) 2005-10-25
CN1133423C (zh) 2004-01-07
US5897852A (en) 1999-04-27
PT799613E (pt) 2001-12-28
JP4293643B2 (ja) 2009-07-08
CN1163102A (zh) 1997-10-29
HU220532B1 (hu) 2002-03-28
SA97170715B1 (ar) 2006-10-11
HUP9700556A2 (en) 1997-12-29
IL120202A (en) 2001-03-19
IL120202A0 (en) 1997-06-10
AU1514997A (en) 1997-09-11
DE69705569T2 (de) 2002-05-16
GR3036725T3 (en) 2001-12-31
ZA971734B (en) 1997-09-09
US6106836A (en) 2000-08-22
HU9700556D0 (en) 1997-04-28
AU704629B2 (en) 1999-04-29
EP0799613B1 (en) 2001-07-11
JPH1024090A (ja) 1998-01-27
EP0799613A1 (en) 1997-10-08
DE69705569D1 (de) 2001-08-16
CA2198195A1 (en) 1997-09-07
KR100458370B1 (ko) 2005-07-07

Similar Documents

Publication Publication Date Title
EG23992A (en) Container with freeze-dried vaccine components
EP0599532A3 (en) One-component crosslinkable organosiloxane compositions.
IL109056A0 (en) Vaccine compositions
MY113428A (en) Hepatitis b vaccine
HUP9700926A3 (en) Vitamine d3 analogues, process for producing them and pharmaceutial compositions containing the same
ZA928162B (en) Antibodies in immunosuppression.
EP0610629A3 (en) Curable organopolysiloxane compositions.
EP0641819A3 (en) Process for the preparation of an organosilicone polymer.
EP0700684A3 (de) Zusammensetzungen, enthaltend Prothrombinkomplex-Konzentrat und wenigstens eine weitere Komponente das die Blutgerrinnung fördert, als Gegenmittel für Blut-Anticoagulanzien
EP0661349A3 (en) Thermosetting silicone composition.
WO2001040177A3 (en) Esters of vitamin d3 and uses thereof
EP0247326A3 (en) Resin compositions, laminates and block copolymers as components thereof
ZA943316B (en) Process for the preparation of microballs and microballs thus obtained.
AU5639390A (en) Gangliotetraosylceramide as an adsorbent for enteric viral pathogens
GB9326425D0 (en) Vaccine compositions
CY2411B1 (en) Compositions.
AR244690A1 (es) Compuestos con grupos triazol,tetrahidrofurano y fenilo,composicion fungicida que los contiene,procedimiento de preparacion de dichos compuestos y compuestos intermedios utilizados en los mismos.
EP0634335A3 (en) Foot to add a box to a box pallet.
HK135494A (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
DE69023630D1 (de) Anordnung zur korrektur des vertikalen kommafehlers.
AP2000001746A0 (en) Anti- first-pass effect compounds.
HU910823D0 (en) Motor-car utilizable as moto-cycle
EP0402160A3 (en) Amine-alkylborane derivatives and methods
IL100221A0 (en) Compositions based on polyphosphazene,particularly for floor covering
SI0793495T1 (en) Freeze-dried ondansetron compositions